MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0059678
Safelife Pharma Speciality Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.73 Cr
▲ 24% YoY
Net profit · FY 2024
₹14.65 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹55.12 Lakh
EBITDA margin 4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹4.54 Cr
Satisfied ₹49 Lakh
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Safelife Pharma Speciality Private Limited
Data last updated:
Safelife Pharma Speciality Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC281825. Its GSTIN is 27AAXCS1442E1Z5 (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Girish Sanktha Prasad Mishra and Shubha Girish Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.73 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹14.65 Lakh (net margin 1.1%) and EBITDA of ₹55.12 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 65% over five years.
The company is associated with 1 brand: Safelifespeciality. As per MCA filings, the company has open charges of ₹4.54 Cr and satisfied charges of ₹49 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
Safelife Pharma Speciality Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0059678). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website safelifespeciality.com.
Company details
CIN U74999MH2016PTC281825
Registration Number 281825
Incorporation Date 31 May 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0059678
Key People
Girish Sanktha Prasad Mishra Director Shubha Girish Mishra Director Sandeep Sankatha Mishra Director Recognitions & Rankings of Safelife Pharma Speciality
Contact details
Safelife Pharma Speciality Private Limited's registered office is in Mumbai, Maharashtra. Its website is safelifespeciality.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No 8 Survey No 164 Cts No 39Pt Khindipada Duck Line Bhandup, West, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Safelife Pharma Speciality Private Limited, buy the company report.
Comprehensive company report
Safelife Pharma Speciality Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Safelife Pharma Speciality operates one associated brand: Safelifespeciality. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specialty pharma distribution and retail operations in India. | safelifespeciality.com |
Business activity
The main business activity of Safelife Pharma Speciality is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Safelife Pharma Speciality Private Limited, buy the company report.
Financials of Safelife Pharma Speciality Private Limited
FY 2025 filings availableSafelife Pharma Speciality Private Limited reported revenue of ₹13.73 Cr (up 24% YoY) for FY 2024.
Revenue · FY 2024
₹13.73 Cr ▲ 24%
Net profit · FY 2024
₹14.65 Lakh margin 1.1%
EBITDA · FY 2024
₹55.12 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▼ 4%
5 years · compounded
▲ 65%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 28%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years, including 24% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Safelife Pharma Speciality Private Limited, buy the company report.
Board of directors of Safelife Pharma Speciality Private Limited
Safelife Pharma Speciality has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Sanktha Prasad Mishra Also directs: Association of Advanced Learners in Medicine, Sarvabhav Foundation | Director | 03 Mar 2018 | 8 Years 8 Months | Current |
| Shubha Girish Mishra | Director | 03 Mar 2018 | 8 Years 8 Months | Current |
| Sandeep Sankatha Mishra Also directs: Sarvabhav Foundation | Director | 03 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Safelife Pharma Speciality Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unilex Lifesciences Private Limited | ₹13.82 Cr (FY 2024) | 22.0% | Panampilly Nagar, Kerala, India | |||
| Safelife Pharma Speciality Private Limitedthis company | ₹13.73 Cr (FY 2024) | ₹14.65 Lakh | 1.1% | 24.0% | Mumbai, Maharashtra, India | |
| Devoir Lifesciences Private Limited | ₹13.7 Cr (FY 2025) | 41.0% | Ludhiana, Punjab, India | |||
| Plenum Biotech Private Limited | ₹13.69 Cr (FY 2024) | 50.0% | Chandigarh, India |
To see the full peer comparison of Safelife Pharma Speciality Private Limited, buy the company report.
Auditor
Safelife Pharma Speciality Private Limited is audited by HNM and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HNM and Company | FY 2023 | 127259W |
Shareholding
The shareholding of Safelife Pharma Speciality Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Safelife Pharma Speciality Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.54 Cr
Satisfied charges
₹49 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2022 | 100575822 | Others | ₹3.82 Lakh | Open | |
| 25 Sep 2018 | 100209735 | Others | ₹4.5 Cr | Open | |
| 01 Sep 2020 | 100377816 | Others | ₹32 Lakh | Satisfied | |
| 17 Aug 2020 | 100377815 | Others | ₹17 Lakh | Satisfied |
To see the full charge records of Safelife Pharma Speciality Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Safelife Pharma Speciality Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Arbitration matter | Filed against the company by M/S.Accord Life Spec Private Limited, | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by Accord Life Spec Private Limited | Disposed |
To see the full case history of Safelife Pharma Speciality Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Safelife Pharma Speciality Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Safelife Pharma Speciality has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS1442E1Z5 | Maharashtra | Active | 12 Apr 2018 |
| 07AAXCS1442E1Z7 | Delhi | Active | 18 May 2018 |
To see the full GST registrations and return filing status of Safelife Pharma Speciality Private Limited, buy the company report.
Recent activity
Safelife Pharma Speciality Private Limited has 9 board changes on record since 2016: 3 appointments and 6 cessations. The latest: Chirag Samir Desai ceased to be Additional Director on 18 Oct 2022.
AGM
Safelife Pharma Speciality Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Safelife Pharma Speciality Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 01 Sep 2020 via Charge ID 100377816 with Others was fully satisfied on 31 Dec 2024.
Charges
A charge registered on 17 Aug 2020 via Charge ID 100377815 with Others was fully satisfied on 31 Dec 2024.
Charges
A charge with Others of Rs. 3.82 Lakh registered on 09 May 2022 with Charge ID 100575822 was modified on 27 Dec 2024.
Charges
A charge with Others of Rs. 450.00 Lakh registered on 25 Sep 2018 with Charge ID 100209735 was modified on 27 Dec 2024.
Ceased
Chirag Samir Desai ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 3.82 Lakh with Charge ID 100575822 was registered on 09 May 2022.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 100377816 was registered on 01 Sep 2020.
Charges
A charge with Others amounted to Rs. 17.00 Lakh with Charge ID 100377815 was registered on 17 Aug 2020.
Charges
A charge with Others amounted to Rs. 450.00 Lakh with Charge ID 100209735 was registered on 25 Sep 2018.
Ceased
Mohamadnasim Ansari ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Safelife Pharma Speciality is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC281825.
Safelife Pharma Speciality has 3 current directors:
- Girish Sanktha Prasad Mishra - Director
- Shubha Girish Mishra - Director
- Sandeep Sankatha Mishra - Director
The latest financial statements of Safelife Pharma Speciality on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Safelife Pharma Speciality is 27AAXCS1442E1Z5, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAXCS1442E1Z7 (Delhi).
The CIN (Corporate Identification Number) of Safelife Pharma Speciality is U74999MH2016PTC281825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Safelife Pharma Speciality has 2 court cases on record: 2 filed against it.
Safelife Pharma Speciality was incorporated on 31 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Safelife Pharma Speciality by revenue are Unilex Lifesciences Private Limited, Devoir Lifesciences Private Limited, Plenum Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Chirag Samir Desai ceased to be Additional Director on 18 Oct 2022. Mohamadnasim Ansari ceased to be Director on 05 Mar 2018. Smita Mukund Bilolikar ceased to be Director on 05 Mar 2018. Safelife Pharma Speciality has 9 board changes on record in total.
Yes, Safelife Pharma Speciality is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0059678).
Safelife Pharma Speciality can be reached through the website safelifespeciality.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages